Publication Detail
| Citation : |
Won S, Hong RA, Shohet RV, Seto TB, Parikh NI. (2013)
Methamphetamine-associated cardiomyopathy.
Clin Cardiol 36(12):737-42.
|
| Abstract : |
Methamphetamine and related compounds are now the second most commonly used illicit substance worldwide, after cannabis. Reports of methamphetamine-associated cardiomyopathy (MAC) are increasing, but MAC has not been well reviewed. This analysis of MAC will provide an overview of the pharmacology of methamphetamine, historical perspective and epidemiology, a review of case and clinical studies, and a summary of the proposed mechanisms for MAC. Clinically, many questions remain, including the appropriate therapeutic interventions for MAC, the incidence and prevalence of cardiac pathology in methamphetamine users, risk factors for developing MAC, and prognosis of these patients. In conclusion, recognition of the significance of MAC among physicians and other medical caregivers is important given the growing use of methamphetamine and related stimulants worldwide.
|
| URL Link : |
http://www.ncbi.nlm.nih.gov/pubmed/24037954
|
| PMID : |
24037954
|
| PMCID : |
PMC4319790
|
|
|
Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.
